Molecular & Cellular Oncology (Jul 2019)
Insights into mitotic checkpoint by integrating CRISPR and RNAi
Abstract
Our recent study of the mitotic checkpoint protein BUB1 (budding uninhibited by benzimidazoles 1) revealed several apparent BUB1 knock-out cell lines expressing low levels of BUB1 protein sufficient to support spindle assembly checkpoint activity. This rings alarm bells on the application of CRISPR technology.
Keywords